Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Intrauterine Device (IUD) Placement at the Time of Cesarean Section

This study has been withdrawn prior to enrollment.
(Principal Investigator left the University of Kentucky before enrollment could begin.)
Duramed Research
Information provided by (Responsible Party):
University of Kentucky Identifier:
First received: September 25, 2009
Last updated: August 12, 2013
Last verified: August 2013
To evaluate the continuation of the Copper IUD at one year after placement through the cesarean incision into the uterus at the time of cesarean section.

Intrauterine Device Placement

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Pilot Study of Copper IUD Placement at the Time of Cesarean Section

Resource links provided by NLM:

Further study details as provided by University of Kentucky:

Primary Outcome Measures:
  • Continuation at one year [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • satisfaction with placement at time of cesarean [ Time Frame: 4-6 months and 1 year ] [ Designated as safety issue: No ]
  • bleeding profile [ Time Frame: 6 months ] [ Designated as safety issue: No ]

Enrollment: 0
Study Start Date: August 2008
Study Completion Date: July 2010
Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
women who have an IUD placed at the time of c-section


Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
pregnant women ages 18-40 who are undergoing a scheduled cesarean section, or women who are attempting to VBAC and want an IUD post partum will be eligible.

Inclusion Criteria:

  • Desire an IUD post-partum and are willing to use the copper IUD.
  • They will also need to be patients at one of our OBGYN clinics at the university of Kentucky.

Exclusion Criteria:

  • Post-partum hemorrhage,
  • Chorioamnionitis (or a fever >101 at the time of cesarean),
  • Women on antibiotic or immunosuppressive therapies,
  • Cervical dilation > 5 cm at the time of c-section, OR
  • Excessive intraoperative blood loss.
  • Also women with contraindications to a copper IUD: Wilson's disease, unusual uterine shape or known uterine anomaly.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

Responsible Party: University of Kentucky Identifier: NCT00986089     History of Changes
Other Study ID Numbers: 08-0938-F6A 
Study First Received: September 25, 2009
Last Updated: August 12, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by University of Kentucky:
Copper IUD
cesarean section
immediate post-partum
continuation processed this record on December 06, 2016